Literature DB >> 20155601

Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review.

Natascha Wilson1, Jean Lud Cadet.   

Abstract

There is a need to bridge the gap between the fields of addiction psychiatry and general psychiatry to effectively treat co-morbid substance abuse and psychiatric disorders. This alarming epidemic transcends communities and severely impacts healthcare worldwide, yielding poor treatment outcomes and prognoses for afflicted patients. Because substance abuse can exacerbate or trigger psychosis and mood disorders, it is important to keep these issues in the forefront when evaluating patients. To address some of the complications stemming from not enough interactions between various groups of practitioners, this review addresses the neurobehavioral effects of cannabis use and their impact on patients who suffer from psychotic or affective disorders. The hope is that this article will serve as a spring board for further discussions among practitioners who treat these patients. Greater interactions between caretakers are bound to impact the care of our patients in a very positive way.

Entities:  

Mesh:

Year:  2009        PMID: 20155601      PMCID: PMC2922015          DOI: 10.1080/10550880903182960

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  138 in total

1.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

2.  Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents.

Authors:  S K Mikulich; S K Hall; E A Whitmore; T J Crowley
Journal:  Drug Alcohol Depend       Date:  2001-02-01       Impact factor: 4.492

3.  Testing hypotheses about the relationship between cannabis use and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall; Michael Lynskey
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

4.  Cerebral hemodynamics and processing speed during category learning.

Authors:  Daniel Schuepbach; Jean-Pierre Bader; Daniel Hell; Ralf W Baumgartner
Journal:  Neuroreport       Date:  2004-05-19       Impact factor: 1.837

Review 5.  The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings.

Authors:  S M Strakowski; M P Delbello; C M Adler
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

6.  Adults seeking treatment for marijuana dependence: a comparison with cocaine-dependent treatment seekers.

Authors:  A J Budney; K J Radonovich; S T Higgins; C J Wong
Journal:  Exp Clin Psychopharmacol       Date:  1998-11       Impact factor: 3.157

7.  Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

Authors:  Deepak Cyril D'Souza; Walid Michel Abi-Saab; Steven Madonick; Kimberlee Forselius-Bielen; Anne Doersch; Gabriel Braley; Ralitza Gueorguieva; Thomas B Cooper; John Harrison Krystal
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

8.  The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention.

Authors:  Judit Balázs; Franco Benazzi; Zoltán Rihmer; Annamária Rihmer; K K Akiskal; H S Akiskal
Journal:  J Affect Disord       Date:  2006-02-03       Impact factor: 4.839

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 10.  Clinical aspects of substance abuse in persons with schizophrenia.

Authors:  Juan C Negrete
Journal:  Can J Psychiatry       Date:  2003-02       Impact factor: 4.356

View more
  8 in total

Review 1.  Treatment of substance abusing patients with comorbid psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  Addict Behav       Date:  2011-09-14       Impact factor: 3.913

2.  Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.

Authors:  Aine T Behan; Magdalena Hryniewiecka; Colm M P O'Tuathaigh; Anthony Kinsella; Mary Cannon; Maria Karayiorgou; Joseph A Gogos; John L Waddington; David R Cotter
Journal:  Neuropsychopharmacology       Date:  2012-03-21       Impact factor: 7.853

3.  Profiles Associated Respectively with Substance Dependence Only, Mental Disorders Only and Co-occurring Disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Jean Caron
Journal:  Psychiatr Q       Date:  2015-09

4.  Predictors of alcohol and drug dependence.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Michel Perreault; Jean Caron
Journal:  Can J Psychiatry       Date:  2014-04       Impact factor: 4.356

Review 5.  Integrated treatment of substance use and psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley
Journal:  Soc Work Public Health       Date:  2013

Review 6.  Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin.

Authors:  Verónica Bisagno; Jean Lud Cadet
Journal:  Behav Pharmacol       Date:  2014-09       Impact factor: 2.293

7.  A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies.

Authors:  Karina Karolina Kedzior; Lisa Tabata Laeber
Journal:  BMC Psychiatry       Date:  2014-05-10       Impact factor: 3.630

8.  Health-related quality of life in patients treated with atypical antipsychotics.

Authors:  Juliana L de Almeida; Isabella de Figueiredo Zuppo; Saulo Castel; Edna A Reis; Helian N de Oliveira; Cristina M Ruas
Journal:  Braz J Psychiatry       Date:  2020 Nov-Dec       Impact factor: 2.697

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.